Annual CFF
$7.52 M
-$881.20 K-10.49%
December 31, 2023
Summary
- As of February 7, 2025, NDRA annual cash flow from financing activities is $7.52 million, with the most recent change of -$881.20 thousand (-10.49%) on December 31, 2023.
- During the last 3 years, NDRA annual CFF has fallen by -$4.36 million (-36.69%).
- NDRA annual CFF is now -43.90% below its all-time high of $13.40 million, reached on December 31, 2021.
Performance
NDRA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$1700.00
-$7.34 M-99.98%
September 30, 2024
Summary
- As of February 7, 2025, NDRA quarterly cash flow from financing activities is $1700.00, with the most recent change of -$7.34 million (-99.98%) on September 30, 2024.
- Over the past year, NDRA quarterly CFF has dropped by -$1.11 million (-99.85%).
- NDRA quarterly CFF is now -99.99% below its all-time high of $12.58 million, reached on March 31, 2021.
Performance
NDRA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$9.48 M
-$1.11 M-10.50%
September 30, 2024
Summary
- As of February 7, 2025, NDRA TTM cash flow from financing activities is $9.48 million, with the most recent change of -$1.11 million (-10.50%) on September 30, 2024.
- Over the past year, NDRA TTM CFF has increased by +$3.63 million (+62.16%).
- NDRA TTM CFF is now -61.18% below its all-time high of $24.42 million, reached on March 31, 2021.
Performance
NDRA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NDRA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.5% | -99.8% | +62.2% |
| 3 y3 years | -36.7% | -99.8% | +62.2% |
| 5 y5 years | -13.3% | -99.8% | +62.2% |
NDRA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -43.9% | at low | -100.0% | -100.0% | -29.3% | +467.1% |
| 5 y | 5-year | -43.9% | at low | -100.0% | -100.0% | -61.2% | +467.1% |
| alltime | all time | -43.9% | +795.9% | -100.0% | -100.0% | -61.2% | >+9999.0% |
ENDRA Life Sciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1700.00(-100.0%) | $9.48 M(-10.5%) |
| Jun 2024 | - | $7.34 M(+1465.0%) | $10.59 M(+32.6%) |
| Mar 2024 | - | $468.90 K(-72.0%) | $7.99 M(+6.2%) |
| Dec 2023 | $7.52 M(-10.5%) | $1.67 M(+50.1%) | $7.52 M(+28.6%) |
| Sep 2023 | - | $1.11 M(-76.5%) | $5.85 M(+23.5%) |
| Jun 2023 | - | $4.73 M(>+9900.0%) | $4.73 M(-37.3%) |
| Mar 2023 | - | $0.00(0.0%) | $7.55 M(-10.2%) |
| Dec 2022 | $8.40 M(-37.3%) | $0.00(0.0%) | $8.40 M(-3.7%) |
| Sep 2022 | - | $0.00(-100.0%) | $8.72 M(-5.4%) |
| Jun 2022 | - | $7.55 M(+783.4%) | $9.22 M(+451.3%) |
| Mar 2022 | - | $854.10 K(+166.0%) | $1.67 M(-87.5%) |
| Dec 2021 | $13.40 M(+12.9%) | $321.10 K(-35.3%) | $13.40 M(-28.2%) |
| Sep 2021 | - | $496.60 K(>+9900.0%) | $18.65 M(-20.0%) |
| Jun 2021 | - | $0.00(-100.0%) | $23.32 M(-4.5%) |
| Mar 2021 | - | $12.58 M(+125.8%) | $24.42 M(+105.6%) |
| Dec 2020 | $11.88 M | $5.57 M(+7.9%) | $11.88 M(-2.2%) |
| Sep 2020 | - | $5.17 M(+370.7%) | $12.15 M(+28.2%) |
| Jun 2020 | - | $1.10 M(+2699.7%) | $9.47 M(+13.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $39.20 K(-99.3%) | $8.37 M(+0.5%) |
| Dec 2019 | $8.34 M(-3.9%) | $5.84 M(+134.7%) | $8.34 M(-18.5%) |
| Sep 2019 | - | $2.49 M(>+9900.0%) | $10.23 M(+32.2%) |
| Jun 2019 | - | $0.00(0.0%) | $7.74 M(-10.8%) |
| Mar 2019 | - | $0.00(-100.0%) | $8.67 M(0.0%) |
| Dec 2018 | $8.67 M(-1.1%) | $7.74 M(>+9900.0%) | $8.67 M(+827.2%) |
| Sep 2018 | - | $0.00(-100.0%) | $935.30 K(0.0%) |
| Jun 2018 | - | $935.30 K(>+9900.0%) | $935.30 K(-89.3%) |
| Dec 2017 | $8.77 M(+508.1%) | $0.00(0.0%) | $8.77 M(0.0%) |
| Sep 2017 | - | $0.00(-100.0%) | $8.77 M(-2.1%) |
| Jun 2017 | - | $8.54 M(+3695.9%) | $8.95 M(+455.6%) |
| Mar 2017 | - | $225.00 K(>+9900.0%) | $1.61 M(+11.8%) |
| Dec 2016 | $1.44 M(+71.8%) | $0.00(-100.0%) | $1.44 M(0.0%) |
| Sep 2016 | - | $187.00 K(-84.4%) | $1.44 M(+14.9%) |
| Jun 2016 | - | $1.20 M(+2080.7%) | $1.25 M(+2180.7%) |
| Mar 2016 | - | $55.00 K | $55.00 K |
| Dec 2015 | $839.20 K(-52.1%) | - | - |
| Dec 2014 | $1.75 M | - | - |
FAQ
- What is ENDRA Life Sciences annual cash flow from financing activities?
- What is the all time high annual CFF for ENDRA Life Sciences?
- What is ENDRA Life Sciences annual CFF year-on-year change?
- What is ENDRA Life Sciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ENDRA Life Sciences?
- What is ENDRA Life Sciences quarterly CFF year-on-year change?
- What is ENDRA Life Sciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for ENDRA Life Sciences?
- What is ENDRA Life Sciences TTM CFF year-on-year change?
What is ENDRA Life Sciences annual cash flow from financing activities?
The current annual CFF of NDRA is $7.52 M
What is the all time high annual CFF for ENDRA Life Sciences?
ENDRA Life Sciences all-time high annual cash flow from financing activities is $13.40 M
What is ENDRA Life Sciences annual CFF year-on-year change?
Over the past year, NDRA annual cash flow from financing activities has changed by -$881.20 K (-10.49%)
What is ENDRA Life Sciences quarterly cash flow from financing activities?
The current quarterly CFF of NDRA is $1700.00
What is the all time high quarterly CFF for ENDRA Life Sciences?
ENDRA Life Sciences all-time high quarterly cash flow from financing activities is $12.58 M
What is ENDRA Life Sciences quarterly CFF year-on-year change?
Over the past year, NDRA quarterly cash flow from financing activities has changed by -$1.11 M (-99.85%)
What is ENDRA Life Sciences TTM cash flow from financing activities?
The current TTM CFF of NDRA is $9.48 M
What is the all time high TTM CFF for ENDRA Life Sciences?
ENDRA Life Sciences all-time high TTM cash flow from financing activities is $24.42 M
What is ENDRA Life Sciences TTM CFF year-on-year change?
Over the past year, NDRA TTM cash flow from financing activities has changed by +$3.63 M (+62.16%)